As a LOS TRES result of this achievement

As a reveals los tres unplugged result of los petinellis imparts this achievement wenow expect full commercialization of this new allograft by June 2009.Additionally, we are currently planning first quarter launches of two key newproducts, the Firebird pedicle screw system and the PILLAR SA interbody device.Steps have also been taken to rationalize expenses and create greater supplychain efficiencies. And, Orthofix announced a $10 million partial debt repaymentin December. This payment was made ahead of the debt`s maturity date and is areflection of the confidence that the Board and management have in the expectedperformance of all our businesses going forward, including Blackstone. In short, the Board unanimously believes the Ramius proposal runs counter to thebest interests of Orthofix`s shareholders.

The request to call a special meetingof shareholders will waste money and cause needless distraction for ourmanagement team, which we would prefer remain focused on our businesses los tres mosketeros . Webelieve if Ramius chooses to spend money in such an inefficient and, frankly,wasteful way, those dollars should come from Ramius, not from all of Orthofix`sshareholders los mosqueperros . To that end, if a special meeting results from the current consentsolicitation process, we would expect that Ramius will fully pay the costs ofany such special meeting Sincerely, James F los magos . Gero Chairman, Board of Directors About OrthofixOrthofix International, N.V., a global medical device company, offers a broadline of minimally invasive surgical, and non-surgical, products for the spine,orthopedic, and sports medicine market sectors that address the lifelongbone-and-joint health needs of patients of all ages-helping them achieve a moreactive and mobile lifestyle dia tres . Orthofix`s products are widely distributed aroundthe world to orthopedic surgeons and patients via Orthofix`s salesrepresentatives and its subsidiaries, including BREG, Inc. and BlackstoneMedical, Inc., and via partnerships with other leading orthopedic productcompanies. In addition, Orthofix is collaborating in R&D partnerships withleading medical institutions such as the Musculoskeletal Transplant Foundation,the Orthopedic Research and Education Foundation, Rutgers University, theCleveland Clinic Foundation, Texas Scottish Rite Hospital for Children andNational Osteoporosis Institute.

For more information about Orthofix, pleasevisit Forward-Looking StatementsThis communication contains certain forward-looking statements under the PrivateSecurities Litigation Reform Act of 1995 los tres letras . These forward-looking statements,which may include, but are not limited to, statements concerning theprojections, financial condition, results of operations and businesses ofOrthofix and its subsidiaries and are based on management`s current expectationsand estimates and involve risks and uncertainties that could cause actualresults or outcomes to differ materially from those contemplated by theforward-looking statements los tre reyes magos . Factors that could cause or contribute to such differences may include, but arenot limited to, risks relating to the expected sales of its products, includingrecently launched products, unanticipated expenditures, changing relationshipswith customers, suppliers and strategic partners, risks relating to theprotection of intellectual property, changes to the reimbursement policies ofthird parties, changes to and interpretation of governmental regulation ofmedical devices, the impact of competitive products, changes to the competitiveenvironment, the acceptance of new products in the market, conditions of theorthopedic industry and the economy, corporate development and marketdevelopment activities, including acquisitions or divestitures, unexpected costsor operating unit performance related to recent acquisitions and other factorsdescribed in our annual report on Form 10-K and other periodic reports filed bythe Company with the Securities and Exchange Commission los espada . Where You Can Find Additional InformationRamius Capital and certain of its affiliates have filed a definitive proxystatement with the SEC to solicit written requests from shareholders of Orthofixto call a special general meeting of shareholders for the purpose of makingchanges to the composition of Orthofix`s board of directors los chiflados . Orthofix has filedwith the SEC a preliminary proxy statement in connection with its intent tosolicit written requests from shareholders in opposition to Ramius`solicitation. If Orthofix holds a special general meeting at Ramius` and othershareholders` request, Orthofix intends to file with the SEC, and distribute toshareholders, a proxy statement opposing proposals made by Ramius.

SHAREHOLDERSARE URGED TO READ ORTHOFIX`S DEFINITIVE PROXY MATERIALS AND ANY OTHER RELEVANTSOLICITATION MATERIALS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSETHEY WILL CONTAIN IMPORTANT INFORMATION los tres fome . Investors and shareholders may obtain(when they are available) a free copy of proxy statements filed with the SEC byOrthofix at the SEC`s website at or by contacting Georgeson, 199Water Street, 26th Floor, New York, NY 10038 or by calling (212) 440-9800(bankers and brokers) or toll-free (800) 323-4133 (all others) Orthofix International N.V los trios . and its directors and certain executive officers areparticipants in the solicitation of consent revocations from shareholders ofOrthofix, as well as the solicitation of proxies in connection with a specialgeneral meeting of shareholders, if such a meeting is called The names of suchpersons are: James F Gero, Peter J Hewett, Jerry C Benjamin, Charles W.Federico, Dr Guy J Jordan, Ph.D., Thomas J Kester, CPA, Alan W Milinazzo,Maria Sainz, Dr Walter P von Wartburg, Kenneth R Weisshaar, Robert S Vaters,Michael Simpson, Bradley R Mason, Raymond C Kolls, J.D and Michael M.Finegan los reyes . Information regarding such participants, as well as each such person`srespective interests in Orthofix by security holdings or otherwise, is set forthin Orthofix`s proxy statement relating to the 2008 annual general meeting ofshareholders, which may be obtained free of charge at the SEC`s website at and Orthofix`s website at More current informationregarding such persons, as well as each such person's respective interests inOrthofix by security holdings or otherwise, will be set forth in the definitiveproxy statement materials to be filed with the SEC and distributed toshareholders by Orthofix as described above los trio . Orthofix International N.V.Dan Yarbrough, 617-912-2903Vice President of Investor Copyright Business Wire 2009.

COLUMBUS, Ohio--(Business Wire)--Cummins Inc . (NYSE:CMI) reaffirmed today that its entire on-highway productrange, including its industry-leading ISX, will be ready to meet the newEnvironmental Protection Agency (EPA) regulations for the North American marketbeginning in 2010 los tre reyes . The breadth of Cummins 2010 product offerings demonstratesCummins commitment to its customers as well as to the environment los tre chiflados . Customers` concerns for economic solutions and satisfying environmentalregulation will be the hallmark of Cummins product line .